Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wasan

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|September 1, 2012
Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trialA Madi, D Fisher, R H Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upA Krämer, T Bochtler, C Pauli, et al.
Gut|October 12, 2002
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus documentS A Khan, B R Davidson, R Goldin, et al.
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 17, 2007
Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumoursL R Jiao, T Szyszko, A Al-Nahhas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancerJ Bridgewater, A Lopes, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancerD Cunningham, B Sirohi, A Pluzanska, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
Heliyon|September 28, 2018
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)R Glynne-Jones, M R Hall, A Lopes, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|September 1, 2012
Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trialA Madi, D Fisher, R H Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2022
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upA Krämer, T Bochtler, C Pauli, et al.
Gut|October 12, 2002
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus documentS A Khan, B R Davidson, R Goldin, et al.
ESMO Open|December 13, 2021
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC studyJ Tabernero, L Velez, T L Trevino, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 17, 2007
Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumoursL R Jiao, T Szyszko, A Al-Nahhas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancerJ Bridgewater, A Lopes, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2008
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancerD Cunningham, B Sirohi, A Pluzanska, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
ESMO Open|June 2, 2022
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRCS Kopetz, A Grothey, E Van Cutsem, et al.
Heliyon|September 28, 2018
BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)R Glynne-Jones, M R Hall, A Lopes, et al.
Pageof 4